DEFINITIVE CONTRACT
Active75F40126C00218
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$12.9M
obligated · signed 7 days ago
BEST 1 CONTRACT
Performance timeline
Start
Sep 30, 2026
Current end
Sep 29, 2027
Potential end
Sep 29, 2029
with all options
Loading status
Estimated start: Sep 29, 2028
ACUMEN LLC
Contract 75F40126C00218
UEI
XVMTJF1497P1
Parent Company
ACUMEN LLC
Capabilities & Certifications
Headquarters Location
Congressional District: 15
Current Obligation
$12,919,772
Base + Exercised Options
$12,919,772
Total Ceiling Value
$40,818,212
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
PSC
HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH
Place of Performance
Congressional District: 15
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.